Table of Contents Table of Contents
Previous Page  835 / 1631 Next Page
Information
Show Menu
Previous Page 835 / 1631 Next Page
Page Background

• Patients with residual fluorodeoxyglucose-avid disease after four

cycles of R-CHOP were recommended RT regardless of

randomization

• These patients achieved similarly favorable outcome to those with

a PET CR after R-CHOP with or without RT, suggesting a role for

RT in patients who achieve only a PR to chemotherapy